Jim Cramer gives mixed views on AstraZeneca, Joby and other stocks

Verifying
  • Jim Cramer discussed AstraZeneca, Joby Aviation, Trinity Industries and other stocks on Mad Money.
  • Joby reported a 25-cent quarterly loss, missing the 23-cent consensus estimate.
  • Grab approved a $750 million buyback after raising FY26 sales guidance.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.